Agenda

CHINA PRETRIALS 2011 ADVISORY BOARD

Ernest Bush, Ph.D. Vice President & Scientific Director CHINA PRECLINICAL MANAGEMENT SERVICES	John Gong, Ph.D, M.D. Vice President & CTO JOINN LABORATORIES	Gene Hsu, Ph.D., DABT Deputy Director NATIONAL SHANGHAI CENTER FOR NEW DRUG SAFETY & EVALUATION RESEARCH

Helen Han Hsu, Ph.D., DVM Vice President, Head of Preclinical Development, Asia Pacific JOHNSON & JOHNSON PRD	Edward Hu, Ph.D. Chief Operating Officer WUXI APPTEC	Ada Kung, Ph.D. Senior Vice President, Preclinical Development TAIGEN BIOTECHNOLOGY

Jo Oliver Scinovo China Head/Preclinical Development GLAXOSMITHKLINE R&D CHINA	Jianfei Wang, Ph.D. Director, Laboratory Animal Science GLAXOSMITHKLINE R&D CHINA	Yi Yang, M.D., Ph.D. Head of Preclinical Safety, China R&D SANOFI-AVENTIS

About Your Organizer

Jon E. Liong, Managing Partner, LYCHEE GROUP
Jon brings 10 years of success in the strategic planning, organization and marketing of over 100 pharmaceutical and biotech business-to-business conferences. He conceived and launched the "IMPACT CHINA: Pharmaceutical Global R&D" series, which was the first-ever global R&D event covering China's life sciences industry. The meeting helped foster early collaborations between Western companies and all aspects of China's nascent pharmaceutical industry.